Ural, A Ugur <br/><br/>
The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.  [electronic resource] 

 -  International journal of hematology  Dec 2003 
 - 443-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0925-5710 
<br/><br/><label>Standard No.: </label>10.1007/BF02983818  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Calcium--metabolism<br/>Cell Cycle--drug effects<br/>Cell Division--drug effects<br/>Dexamethasone--pharmacology<br/>Diphosphonates--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Egtazic Acid--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Imidazoles--pharmacology<br/>Leukemia, Plasma Cell--pathology<br/>Multiple Myeloma--pathology<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Protein Kinase C--antagonists & inhibitors<br/>Staurosporine--pharmacology<br/>Thalidomide--pharmacology<br/>Tumor Cells, Cultured--drug effects<br/>Zoledronic Acid